Expert summit, From Care to Cure – Towards the Elimination of HIV, kicks off in St. Lucia

The 15th annual Caribbean Cytometry & Analytical Society’s (CCAS) expert summit, “From Care to Cure – Towards the Elimination of HIV”, launched last evening in St. Lucia.

The summit brings together regional and international HIV experts to explore scientific innovations and social interventions that will accelerate progress toward ending the AIDS epidemic as a public health threat. It runs from August 26th to 30th.

Speaking at the opening ceremony at the Coco Palm Hotel last evening, CCAS Chairperson, Professor Clive Landis pointed to successes of the Caribbean HIV response including the validation of seven countries and territories as having eliminated mother-to-child HIV transmission. He noted that while the region has embraced the power of antiretroviral treatment and viral suppression to prevent HIV infections in newborns, there is inadequate understanding among the general public about ho

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below